Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Escitalopram × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1 CNS 1 Breast 1

Conditions

Interventions

Temozolomide 520 Radiotherapy 330 Bevacizumab 215 Magnetic Resonance Spectroscopy 173 Cyclophosphamide 148 Carboplatin 135 Radiosurgery 132 Etoposide 110 Radiation 99 Irinotecan 99 Vincristine 93 Cisplatin 82 Filgrastim 81 pembrolizumab 74 Specimen Handling 73 Lomustine 73 Nivolumab 71 Surgical Procedures, Operative 58 Topotecan 57 Melphalan 51 Carmustine 50 Radiotherapy, Intensity-Modulated 45 Doxorubicin 45 sargramostim 44 Peripheral Blood Stem Cell Transplantation 44 Granulocyte Colony-Stimulating Factor 44 Isotretinoin 42 Erlotinib Hydrochloride 40 Chemotherapy, Adjuvant 40 Granulocyte-Macrophage Colony-Stimulating Factor 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03728673 2025-06-22

A Study Utilizing Escitalopram in Glioma Patients

University of Nebraska

Phase 2 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡